Table 2.

Included study characteristics for nontreatment trials

Lead author, year Academic vs community	Type of nontreatment study	Study design	Patient consent?	Cancer type	Other restrictions	Recruitment period	Site description
Sears et al., 2003 (56) Academic	Survivorship	Prospectivea/Physician	Yes	Breast	Early stage breast cancer, psychoeducational survivorship intervention	1999-2001	UCLA, University of Kansas, Georgetown University
Grubbs et al., 2009 (33) Community	Cancer control	Retrospective/MR review	No	Leukemia	Patients with CLL	2008	Multiple NCCCP sites
Dignan et al., 2011 (41) Community	Survivorship	Prospective/Physician	Yes	All types	Cancer survivors of any hematologic or solid tumor	2007-2009	Large public hospital in Birmingham, AL
Bernard-Davila et al., 2015 (38) Academic	Survivorship	Prospective/Physician	Yes	Breast	Stage 0-III; Hispanic, urban, Spanish-speaking	2012	Columbia University
Aycinena et al., 2017 (36) Academic	Survivorship	Prospective/Physician	Yes	Breast	Stage 0-III; low-income, urban, Hispanic and AA survivors; overweight	2007-2008	Columbia University

^aIncludes survivorship intervention but observational (ie, no intervention) with respect to participating in a survivorship trial. AA = African American; MR = medical record; CLL = chronic lymphocytic leukemia; NCCCP = National Comprehensive Cancer Control Program; UCLA = University of California, Los Angeles.